Ironwood Pharmaceuticals
IRWD
4.70
-0.01
-0.21%
Ironwood Pharmaceuticals
US · IRWD
#3609 by market cap
4.70
-0.01
-0.21%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Craig-Hallum moved from Hold to Buy on 2026-01-02.
Analyst consensus 1 analysts
Buy
Avg price target 6.00 +27.7%
Price target rangecurrent 4.70
Low6.00
Avg6.00
High6.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (17)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-06 | Craig-Hallum | -- | Buy | 6.00 |
| 2026-07-14 | Craig-Hallum | -- | Buy | -- |
| 2026-05-13 | Craig-Hallum | -- | Buy | -- |
| 2026-05-05 | Wells Fargo | -- | Hold | 5.00 |
| 2026-03-18 | Craig-Hallum | -- | Buy | -- |
| 2026-03-11 | Craig-Hallum | -- | Buy | -- |
| 2026-02-26 | Craig-Hallum | -- | Buy | -- |
| 2026-02-26 | Citizens JMP | -- | Buy | 10.00 |
| 2026-02-23 | Craig-Hallum | -- | Buy | -- |
| 2026-01-05 | Citizens JMP | -- | Buy | 8.00 |
| 2026-01-04 | Wells Fargo | -- | Hold | 5.00 |
| 2026-01-02 | Craig-Hallum | -- | Buy | 5.70 |
| 2025-11-26 | Craig-Hallum | -- | Hold | 3.80 |
| 2025-11-11 | Wells Fargo | -- | Hold | 3.00 |
| 2025-11-10 | Craig-Hallum | -- | Hold | -- |
| 2025-11-06 | Craig-Hallum | -- | Hold | -- |
| 2025-10-29 | Craig-Hallum | -- | Hold | 1.70 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-01-02 | Craig-Hallum | Hold → Buy | 5.70 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | -- | -- | +6.90% |
| 2026/Q2 | 2026-08-06 | -- | ±14.73% | +2.65% (in line) |
| 2026/Q1 | 2026-05-07 | -- | ±13.46% | -13.66% (beat) |
| 2025/Q4 | 2026-02-25 | -- | ±20.65% | -11.35% (in line) |
| 2024/Q4 | 2025-02-27 | -- | -- | -5.26% |
| 2024/Q3 | 2024-11-07 | -- | ±17.16% | -7.54% (in line) |
| 2024/Q2 | 2024-08-08 | -- | ±33.78% | -32.61% (in line) |
| 2024/Q1 | 2024-05-09 | -- | ±19.46% | -17.00% (in line) |
| 2023/Q4 | 2024-02-15 | -- | ±12.91% | -2.98% (in line) |
| 2023/Q3 | 2023-11-09 | -- | ±14.83% | +3.14% (in line) |
| 2023/Q2 | 2023-08-08 | -- | ±16.64% | -9.16% (in line) |
| 2023/Q1 | 2023-05-04 | -- | ±6.66% | +0.67% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:01:04 · For reference only, not investment advice and not tailored to your situation.
Ironwood Pharmaceuticals discussion 0 comments